Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation-Reference-Cited by-同舟云学术

Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation

Published:2015-12 Issue:6 Volume:37 Page:733-744
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Antunes Marina V.,da Fontoura Timm Tatiana Aparecida,de Oliveira Vanessa,Staudt Dilana E.,Raymundo Suziane,Gössling Gustavo,Biazús Jorge V.,Cavalheiro José A.,Rosa Daniela D.,Wallemacq Pierre,Haufroid Vincent,Linden Rafael,Schwartsmann Gilberto

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference37 articles.

1. . Pharmacogenomics of tamoxifen therapy.;Brauch;Clin Chem,2009

2. . Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy.;Antunes;Ther Drug Monit,2012

3. Association between CYP2D6 genotypes and the clinical outcomes of adjuvant tamoxifen for breast cancer: a meta-analysis.;Jung;Pharmacogenomics,2014

4. . Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry.;Teunissen;J Chromatogr B Analyt Technol Biomed Life Sci,2009

5. . Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma.;Murdter;Clin Pharmacol Ther,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross‐Ancestry Genome‐Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations;Clinical Pharmacology & Therapeutics;2023-01-31

2. Factors Influencing Pharmacokinetics of Tamoxifen in Breast Cancer Patients: A Systematic Review of Population Pharmacokinetic Models;Biology;2022-12-28

3. Factors Associated with Plasma Levels of Tamoxifen and its Main Metabolites in Mexican Patients with Breast Cancer;Current Pharmacogenomics and Personalized Medicine;2022-08

4. Interplay of Vitamin D and CYP3A4 Polymorphisms in Endocrine Disorders and Cancer;Endocrinology and Metabolism;2022-06-30

5. Hydroethanolic Extract of Defatted Buchholzia coriacea Seeds Alleviates Tamoxifen-Induced Hepatic Triglyceride Accumulation, Inflammation and Oxidative Distress in Rat;Medicines;2021-12-24